In particular, HCC‐CSCs expressing CD133 were associated with a poor prognosis because they bear great tumourigenic potential, possess greater colony‐forming efficiency and display chemoresistance to the classical anticancer drugs doxorubicin and fluorouracil (Ma et al., 2008b). This evidence concerns the gene PROM1 and hepatocellular carcinoma.